AI Verdict
NTLA has stronger fundamentals based on our AI analysis.
NTLA vs NTIC Fundamental Comparison
| Metric | NTLA | NTIC |
|---|---|---|
| Revenue | $67.7M | $23.3M |
| Net Income | $-412.7M | $237,819.0 |
| Net Margin | -609.9% | 1.0% |
| ROE | -61.5% | 0.3% |
| ROA | -49.0% | 0.2% |
| Current Ratio | 5.08x | 1.77x |
| Debt/Equity | 0.00x | 0.01x |
| EPS | $-3.81 | $0.03 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NTLA vs NTIC: Frequently Asked Questions
Is NTLA or NTIC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NTLA has stronger fundamentals. NTLA is rated SELL (92% confidence) while NTIC is rated SELL (75% confidence). This is not investment advice.
How does NTLA compare to NTIC fundamentally?
Intellia Therapeutics, Inc. has ROE of -61.5% vs NORTHERN TECHNOLOGIES INTERNATIONAL CORP's 0.3%. Net margins are -609.9% vs 1.0% respectively.
Which stock pays higher dividends, NTLA or NTIC?
NTLA has a dividend yield of N/A or no dividend while NTIC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NTLA or NTIC for long term?
For long-term investing, consider that NTLA has SELL rating with 92% confidence, while NTIC has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NTLA vs NTIC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NTLA vs NTIC, the AI consensus favors NTLA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.